Norway
· Delayed Price · Currency is NOK Thor Medical ASA Statistics
Total Valuation
OSL:TRMED has a market cap or net worth of NOK 771.87 million. The enterprise value is 649.22 million.
| Market Cap | 771.87M |
| Enterprise Value | 649.22M |
Important Dates
The last earnings date was Friday, March 28, 2025.
| Earnings Date | Mar 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:TRMED has 314.41 million shares outstanding. The number of shares has increased by 34.90% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 314.41M |
| Shares Change (YoY) | +34.90% |
| Shares Change (QoQ) | +1.36% |
| Owned by Insiders (%) | 3.00% |
| Owned by Institutions (%) | 1.73% |
| Float | 151.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 2.29 |
| P/TBV Ratio | 14.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.38 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -26.92 |
Financial Position
The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.67 |
| Quick Ratio | 5.49 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.03 |
| Interest Coverage | -448.28 |
Financial Efficiency
Return on equity (ROE) is -13.86% and return on invested capital (ROIC) is -9.01%.
| Return on Equity (ROE) | -13.86% |
| Return on Assets (ROA) | -7.37% |
| Return on Invested Capital (ROIC) | -9.01% |
| Return on Capital Employed (ROCE) | -11.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -4.69M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +133.81% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +133.81% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 1.93 |
| Relative Strength Index (RSI) | 53.02 |
| Average Volume (20 Days) | 1,500,439 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -43.93M |
| Pretax Income | -42.64M |
| Net Income | -42.21M |
| EBITDA | -41.55M |
| EBIT | -43.93M |
| Earnings Per Share (EPS) | -0.18 |
Balance Sheet
The company has 123.39 million in cash and 737,000 in debt, giving a net cash position of 122.65 million or 0.39 per share.
| Cash & Cash Equivalents | 123.39M |
| Total Debt | 737,000 |
| Net Cash | 122.65M |
| Net Cash Per Share | 0.39 |
| Equity (Book Value) | 337.14M |
| Book Value Per Share | 1.20 |
| Working Capital | 107.01M |
Cash Flow
In the last 12 months, operating cash flow was -23.98 million and capital expenditures -140,000, giving a free cash flow of -24.12 million.
| Operating Cash Flow | -23.98M |
| Capital Expenditures | -140,000 |
| Free Cash Flow | -24.12M |
| FCF Per Share | -0.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSL:TRMED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -34.90% |
| Shareholder Yield | -34.90% |
| Earnings Yield | -5.47% |
| FCF Yield | -3.12% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |